ADAMTS12 is a stromal modulator in chronic liver disease

Bassil Dekky1, Fida Azar1, Dominique Bonnier1

  • 1University of Rennes, INSERM, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, Rennes, France.

Summary

ADAMTS12, a key adamalysin, modulates hepatic stellate cell differentiation and impacts chronic liver disease progression. Its dysregulation is linked to hepatocellular carcinoma recurrence and fibrosis.